Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

NSRXNSRX
1 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in NASUS PHARMA LTD

CITADEL ADVISORS LLC holds 22,004 shares of NSRX (NASUS PHARMA LTD), worth $77,014 as of 2026-Q2. This is a new position.

Current Value

$77,014

Current Shares

22,004

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
22,004
-
$77,0140.0%$3.50
33

Other major holders of NSRX: BALYASNY ASSET MANAGEMENT L.P., Hudson Bay Capital Management LP, HRT FINANCIAL LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used